Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lymphoma
Phenotype C0019158|hepatitis
Sentences 35
PubMedID- 22736295 Clinical outcome of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis c virus (hcv) infection in the rituximab era remains unclear.
PubMedID- 24778676 Here, we report a case of hhv-8-unrelated pel-like pleural lymphoma in a patient with hepatitis b virus (hbv)-related cirrhosis and ascites but hhv-8 and hiv-negative.
PubMedID- 25947024 [hepatic mucosa-associated lymphoid tissue lymphoma in a patient with chronic hepatitis b].
PubMedID- 24516927 [consensus on the management of lymphoma in patients with hepatitis b virus infection].
PubMedID- 24157019 Liver transplantation in lymphoma patients with hepatitis b virus reactivation.
PubMedID- 21696249 We describe a case of severe acute hepatitis b developing in a patient with hodgkin's lymphoma after chemotherapy and before radiotherapy.
PubMedID- 20876592 Surrogate markers of b cell non-hodgkin's lymphoma in patients with hepatitis c virus-related cryoglobulinaemia vasculitis.
PubMedID- 25030854 Primary hepatic mucosa-associated lymphoid tissue lymphoma and hemangioma with chronic hepatitis b virus infection as an underlying condition.
PubMedID- 21452121 [viral hepatitis b in a patient with follicular lymphoma treated with biological therapy].
PubMedID- 24060287 Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series.
PubMedID- 25381127 The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection.
PubMedID- 23606919 [12] reported that entecavir is more effective than lamivudine in preventing hepatitis b reactivation in patients with lymphoma under chemotherapy.
PubMedID- 20554488 Hcv-positive status and hepatitis flares in patients with b-cell non-hodgkin's lymphoma treated with rituximab-containing regimens.
PubMedID- 24367885 hepatitis b reactivation in patient with non-hodgkin's lymphoma receiving rituximab-based chemotherapy: need for education and attention.
PubMedID- 25024777 Herein we report the unusual case of a systemic marginal zone lymphoma in a patient with hepatitis c infection presenting clinically as localized lipoatrophy.
PubMedID- 25356327 At least ten patients had several underlying diseases and conditions (chronic renal failure, peritoneal dialysis, haemodialysis, human immunodeficiency virus infection, chronic hepatitis, preterm rupture of the membranes, lymphoma, lung cancer, cytotoxic treatment and neutropenia).
PubMedID- 23529561 Primary hepatic lymphoma in a patient with chronic hepatitis b and c infection: diagnostic pitfalls and therapeutic challenge.
PubMedID- 26481866 Hepatosplenic t-cell lymphoma with coexistent hepatitis b infection: a rare clinicopathologic entity.
PubMedID- 23465418 Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection.
PubMedID- 20610938 [icteric hepatitis in a patient with non-hodgkin's lymphoma treated by rituximab-based chemotherapy].
PubMedID- 23323115 Here, we report a case of cervical lymphadenopathy mimicking t-cell lymphoma with hepatitis and splenomegaly after dapsone treatment.
PubMedID- 21887912 We are reporting the case of a 44 years old male who was diagnosed to have hepatitis c infection with lymphoplasmacytic lymphoma and iga nephropathy.
PubMedID- 24851363 [risk of reactivation of hepatitis b in patients with the lymphoma hbsag negative , anti-hbc positive treated with rituximab-chop].
PubMedID- 21188204 In a recently published review of 160 chronic hepatitis c patients with non-hodgkin lymphoma, twenty-four (15%) of them developed significant liver toxicity during chemotherapy [14].
PubMedID- 20807095 The prognosis and management of acute exacerbations of hepatitis-b in patients with lymphoma after chemotherapy in combination with rituximab remain unclear.
PubMedID- 22715204 Primary spleen lymphoma associated with hepatitis c virus infection.
PubMedID- 22395482 B-cell lymphoma in hepatitis c virus (hcv)-seropositive patients frequently presents with extranodal disease in the bone marrow, major salivary glands, or spleen [1, 2].
PubMedID- 25848698 We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection.
PubMedID- 23082489 Genetic profiling of non-hodgkin's lymphoma with or without hepatitis c virus infection.
PubMedID- 25339404 Fatal outcome of autochthonous hepatitis e in a patient with b cell lymphoma in southeastern france.
PubMedID- 25158783 Telomeric 1p36.3 deletion and ki-67 expression in b-non-hodgkin's lymphoma patients associated with chronic hepatitis c virus infection.
PubMedID- 21888689 Vitali [5] examines the differences and similarities of sicca symptoms and risk of developing lymphoma between patients with hiv or hepatitis c virus infection and those with sjögren syndrome.
PubMedID- 20440575 Leading considerations include alcoholic hepatitis, sle with autoimmune hepatitis, lymphoma or an indolent infection.
PubMedID- 23601025 Reactivation of hepatitis b virus in a patient with adult t-cell leukemia-lymphoma receiving the anti-cc chemokine receptor 4 antibody mogamulizumab.
PubMedID- 22855657 [9] in japan reported a case of pancreas lymphoma with chronic hepatitis c. visco et al.

Page: 1